Authors: Knox, SJ Goris, ML Tempero, M Weiden, PL Gentner, L Breitz, H Adams, GP Axworthy, D Gaffigan, S Bryan, K Fisher, DR Colcher, D Horak, ID Weiner, LM

Citation: Sj. Knox et al., Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer, CLIN CANC R, 6(2), 2000, pp. 406-414